People In Brief
This article was originally published in The Gray Sheet
Executive Summary
WorldHeart gets new chief: Cardiac assist technology firm appoints John Alexander "Alex" Martin president and CEO, the company announces Feb. 6. Martin comes from Edwards Lifesciences, where he was president of the North American region since 2004. He was previously an executive at Johnson & Johnson/Cordis, overseeing the launch of the Cypher drug-eluting stent. Martin replaces Jal S. Jassawalla, who served since 2004 and stays on as executive VP and chief technology officer. WorldHeart is developing the Levacor rotary ventricular assist device
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.